Effect of introducing high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children
This is the main finding of a recent article based on data from The Streptococcus pneumoniae Invasive Disease network (SpIDnet).
European Commission: Influenza
Vaccination policy is a competence of national authorities however, the European Commission supports EU countries to coordinate their policies and programmes. To support EU countries in maintaining or increasing rates of vaccination, the EU Commission promotes seasonal flu vaccination to at risk groups.
Low uptake of seasonal influenza vaccination in Europe may jeopardise capacity to protect people in next pandemic
Influenza vaccination coverage among high-risk groups has dropped in the European Region over the last seven years, and half the countries report a decrease in the number of vaccine doses available.
Protocols for case-control studies to measure influenza vaccine effectiveness in the EU and EEA Member States
This publication presents the core European protocol for a series of proposed influenza vaccine effectiveness studies. The protocol includes a proposed plan for pooled analysis and has recently been adapted to measure vaccine effectiveness for the pandemic vaccine in 2009-10. Together with its twin publication ‘Protocols for cohort database studies to measure influenza vaccine effectiveness in the EU and EEA Member States’, this publication covers all methodological issues in the design and implementation of vaccine effectiveness studies, both for seasonal and the new A(H1N1)v influenza.
Assessing seasonal influenza vaccine effectiveness
On 3 December 2015, ECDC hosts a technical meeting to discuss influenza vaccine effectiveness studies and how they can best meet public health needs as well as regulatory requirements.
Efficacy and safety of single and double doses of Ivermectin versus 7-day high dose Albendazole for chronic StrongyloidiasisArchived
A prospective, randomized, open study was conducted in which a 7-day course of oral albendazole 800 mg daily was compared with a single dose (200 microgram/kilogram body weight) or double doses, given 2 weeks apart, of ivermectin in Thai patients with chronic strongyloidiasis.